Greetings, everyone!
I have printed 3D structure for engineered liver tissue and then implanted in a rat liver.
However, I used HepG2 and EA.hy926 for this tissue.
Both cells are cancer cell lines, and they are the current problem in my study.
Other researchers still used cancer cells for in vivo experiment, so I think I should say some sentences in discussion about my issue.
How can we discuss using cancer cell (especially HepG2) for an in vivo implantation/ transplantation experiment?
Thank you all in advance for your valuable insights and contributions to this vital discussion.
Warm regards,
Alex